21-14152629-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_001302998.2(LIPI):c.1062G>A(p.Ser354Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000392 in 1,590,702 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0015 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00027 ( 3 hom. )
Consequence
LIPI
NM_001302998.2 synonymous
NM_001302998.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.827
Genes affected
LIPI (HGNC:18821): (lipase I) The protein encoded by this gene is a phospholipase that hydrolyzes phosphatidic acid to produce lysophosphatidic acid. Defects in this gene are a cause of susceptibility to familial hypertrigliceridemia. This gene is also expressed at high levels in Ewing family tumor cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 21-14152629-C-T is Benign according to our data. Variant chr21-14152629-C-T is described in ClinVar as [Benign]. Clinvar id is 1532871.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.827 with no splicing effect.
BS2
High AC in GnomAd4 at 232 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LIPI | NM_001302998.2 | c.1062G>A | p.Ser354Ser | synonymous_variant | 8/10 | ENST00000681601.1 | NP_001289927.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LIPI | ENST00000681601.1 | c.1062G>A | p.Ser354Ser | synonymous_variant | 8/10 | NM_001302998.2 | ENSP00000505323.1 |
Frequencies
GnomAD3 genomes AF: 0.00153 AC: 232AN: 151956Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
232
AN:
151956
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000510 AC: 127AN: 249130Hom.: 0 AF XY: 0.000467 AC XY: 63AN XY: 134846
GnomAD3 exomes
AF:
AC:
127
AN:
249130
Hom.:
AF XY:
AC XY:
63
AN XY:
134846
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000272 AC: 391AN: 1438628Hom.: 3 Cov.: 27 AF XY: 0.000251 AC XY: 180AN XY: 717078
GnomAD4 exome
AF:
AC:
391
AN:
1438628
Hom.:
Cov.:
27
AF XY:
AC XY:
180
AN XY:
717078
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00153 AC: 232AN: 152074Hom.: 0 Cov.: 32 AF XY: 0.00152 AC XY: 113AN XY: 74322
GnomAD4 genome
AF:
AC:
232
AN:
152074
Hom.:
Cov.:
32
AF XY:
AC XY:
113
AN XY:
74322
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3462
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 29, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at